This resource summarizes recommended immunizations for healthy preteens, adolescents and young adults between the ages of 9 and 25 who have completed recommended childhood vaccinations, and provides counseling points for health care providers.
Some people have worried that thimerosal, an ethylmercury-containing preservative in some multi-dose preparations of influenza vaccine, could cause mercury poisoning in children or affect the unborn children of pregnant women who receive this vaccine. But, for many reasons, thimerosal contained in vaccines is not harmful.
La présente ressource offre une synthèse des vaccins recommandés aux préadolescents, adolescents et jeunes adultes en bonne santé, âgés de 9 à 25 ans, ayant reçu tous les vaccins recommandés durant l’enfance; on y trouve aussi des conseils à l’intention du personnel soignant.
Canada's Provincial and Territorial Routine (and Catch-up) Vaccination Programs for Infants and Children
This table summarizes the current routine vaccination schedule for infants and children in all provinces and territories across Canada. Provincial and territorial schedules change regularly. This schedule is updated four times per year in collaboration with the CNCI and the CIC.
Ensuring that a child new to Canada is up to date with all immunizations poses unique challenges. Confirming or updating childhood immunizations is not a part of the immigration medical examination, and it cannot be assumed that newly arrived children are completely immunized.
The Health Promotion Capacity Building team is part of the Health Promotion, Chronic Disease and Injury Prevention department at Public Health Ontario. The team has many years of experience building capacity in core competencies of public health including the areas of program planning and evaluation, healthy public policies and by-laws including alcohol policy, health communication and social marketing, community and stakeholder engagement, and other health promotion topics.
This Healthy First Nations and Inuit page is a Government of Canada initiative aimed at keeping First Nations and Inuit informed about health related campaigns, and fostering dialogue on various health topics.
Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. It is hoped that this document will be useful to clinicians when faced with questions from parents.